SENATE 474116th CongressRead twice and referred to the Committee on Finance.
Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019
- Last Action
- 2/13/2019
Actions
- 2019-02-13Read twice and referred to the Committee on Finance.
- 2019-02-13Introduced in Senate
Cosponsors (12)
- Ben Cardin (D-MD)
- Thomas Carper (D-DE)
- Christopher Coons (D-DE)
- Tammy Duckworth (D-IL)
- Amy Klobuchar (D-MN)
- Robert Menendez (D-NJ)
- Debbie Stabenow (D-MI)
- Jon Tester (D-MT)
- Kirsten Gillibrand (D-NY)
- Catherine Cortez Masto (D-NV)
- Tina Smith (D-MN)
- Gary Peters (D-MI)
Subjects
- Civil actions and liability
- Corporate finance and management
- Government information and archives
- Inflation and prices
- Marketing and advertising
- Prescription drugs
- Research and development
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.